Hjem › Multipelt myelom › Texas › Lubbock
Multipelt myelom kliniske forsøg i Lubbock, TX
3 studier for Multipelt myelom søger deltagere på steder i og omkring Lubbock (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- Joe Arrington Cancer Research Treatment Center, Lubbock
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruttererFase 3
- Joe Arrington Cancer Research Treatment Center, Lubbock
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RekruttererFase 3
- Joe Arrington Cancer Research and Treatment Center, Lubbock
Multipelt myelom forsøg i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Lubbock
- Crohns sygdom10 studier
- Ulcerøs colitis9 studier
- Brystkræft6 studier
- Ikke-småcellet lungecancer4 studier
- Psoriasisartrit3 studier
- Slagtilfælde3 studier
- Overvægt3 studier
- Overvægt3 studier
- Inflammatorisk tarmsygdom3 studier
- Burkitts lymfom3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.